DRD drug-related deaths (DRD) and Drug-related infectious diseases (DRID) key epidemiological indicators annual expert meetings, and satellite event on naloxone
The DRD/DRID key epidemiological indicators expert meetings was this year again implemented in an integrated format, with some joint sessions. This year, among other topics, the focus was on evidence from overdose and toxicology, mortality cohort studies, cannabis-related emergencies, HCV infections and treatment, HIV outbreaks among drug users, changing and new groups of injectors, emerging risks. There were technical workshops and ‘conference-like’ plenaries. Attendance in the expert meetings was restricted to nominated experts of the 28 EU Member States, Norway and Turkey, and invited speakers. Our EU partners, international organisations and non EU countries were represented.
The DRD/DRID meetings was preceded by a half-day satellite event entitled Take home naloxone to reduce fatalities: scaling up a participatory intervention across Europe, which was open to interested participants who were not in the respective EMCDDA expert networks.
Registration and practical information
The event took place at the EMCDDA’s Conference Centre in Lisbon, Portugal, starting on Tuesday, 14 October 2014 and ending on Friday, 17 October (see agenda on the right). A call for input to the DRD/DRID meeting was sent to the expert networks and proposals for input and abstracts could be submitted until 31 August 2014 (see templates on the side).
Please use the DRD-DRIDemail@example.com for any communication related to the event.